Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 1757 for

Edit search filters
  1. Olaparib In Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. A Study To Compare Administering Olaparib Concurrently With Radiotherapy Vs. Radiotherapy Alone In Treating Patients With Inflammatory Breast Cancer

    Eau Claire, WI, La Crosse, WI, Rochester, MN

  3. BeWell360-CG Care Model: Health And Wellness Coaching To Support Caregivers Of Patients Living With Advanced Lung Cancers

    Jacksonville, FL

  4. CC-220-MM-001: A Phase 1b/2a Multicenter, Open-Label, Dose-Escalation Study To Determine The Maximum Tolerated Dose, Assess The Safety, Tolerability, Pharmacokinetics And Efficacy Of CC-220 As Monotherapy And In Combination With Other Treatments In Subjects With Multiple Myeloma

    Scottsdale/Phoenix, AZ

  5. A Study Of Entrectinib (RXDX-101) For The Treatment Of Patients With Solid Tumors That Have NTRK1/2/3, ROS1, Or ALK Gene Rearrangements

    Scottsdale/Phoenix, AZ

  6. Ommaya Placement For Biomarker Collection

    Rochester, MN

  7. A Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of HPN217 In Patients With Relaped/Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ

  8. A Study Of Enfortumab Vedotin Alone Or With Other Therapies For Treatment Of Urothelial Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  9. A Study Of CART-TnMUC1 In Patients With TnMUC1-Positive Advanced Cancers

    Scottsdale/Phoenix, AZ

  10. A Study Of TNB-383B In Subjects With Relapsed Or Refractory Multiple Myeloma

    Rochester, MN

.

Mayo Clinic Footer